Charles Schwab Trust’s Zoetis ZTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,940
Closed -$319K 183
2025
Q1
$319K Sell
1,940
-1,133
-37% -$188K 0.03% 141
2024
Q4
$501K Sell
3,073
-10
-0.3% -$1.79K 0.04% 110
2024
Q3
$602K Sell
3,083
-5
-0.2% -$921 0.05% 102
2024
Q2
$535K Buy
3,088
+73
+2% +$12.1K 0.05% 111
2024
Q1
$510K Sell
3,015
-46
-2% -$8.62K 0.05% 110
2023
Q4
$604K Sell
3,061
-170
-5% -$30.1K 0.06% 112
2023
Q3
$562K Buy
+3,231
New +$587K 0.06% 116
2022
Q1
Sell
-1,182
Closed -$288K 179
2021
Q4
$288K Sell
1,182
-79
-6% -$17.3K 0.05% 147
2021
Q3
$245K Buy
1,261
+40
+3% +$8.07K 0.05% 164
2021
Q2
$228K Buy
+1,221
New +$212K 0.04% 174

Other funds holding ZTS

Charles Schwab Trust's ZTS Position: Q2 2025 in Review

Charles Schwab Trust sold out of Zoetis (ZTS) in Q2 2025, closing a stake of 1,940 shares — an estimated $319K sold.

Charles Schwab Trust first reported a position in ZTS in Q2 2021 and held it in 10 quarters. The position peaked at $604K in Q4 2023. 1,872 funds tracked by Wall St. Rank hold ZTS as of Q2 2025.

  • Charles Schwab Trust reported no remaining Zoetis position as of Q2 2025 after selling out during the quarter.
  • Charles Schwab Trust sold 1,940 Zoetis shares in Q2 2025, an estimated $319K.
  • Charles Schwab Trust first reported a position in Zoetis in Q2 2021 and held it in 10 quarters.
  • Charles Schwab Trust's Zoetis position peaked at $604K in Q4 2023.
  • 1,872 funds tracked by Wall St. Rank held Zoetis as of Q2 2025.

Based on Charles Schwab Trust's 13F filing for Q2 2025, filed 17 Jul 2025.